Scientists discuss how the synergy between inflammation and thrombosis drives thrombotic diseases. They focus on the huge potential of anti-inflammatory strategies to target cardiovascular pathologies.
[Nature Reviews Cardiology]
6445218 {6445218:D4PS5I3F} apa 50 1 162022 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-4529fa1927bb39854d9e3cf3725225cd%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22D4PS5I3F%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stark%20and%20Massberg%22%2C%22parsedDate%22%3A%222021-05-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EStark%2C%20K.%2C%20%26amp%3B%20Massberg%2C%20S.%20%282021%29.%20Interplay%20between%20inflammation%20and%20thrombosis%20in%20cardiovascular%20pathology.%20%3Ci%3ENature%20Reviews%20Cardiology%3C%5C%2Fi%3E%2C%201%26%23x2013%3B17.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00552-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00552-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DD4PS5I3F%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Interplay%20between%20inflammation%20and%20thrombosis%20in%20cardiovascular%20pathology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Konstantin%22%2C%22lastName%22%3A%22Stark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steffen%22%2C%22lastName%22%3A%22Massberg%22%7D%5D%2C%22abstractNote%22%3A%22Thrombosis%20is%20the%20most%20feared%20complication%20of%20cardiovascular%20diseases%20and%20a%20main%20cause%20of%20death%20worldwide%2C%20making%20it%20a%20major%20health-care%20challenge.%20Platelets%20and%20the%20coagulation%20cascade%20are%20effectively%20targeted%20by%20antithrombotic%20approaches%2C%20which%20carry%20an%20inherent%20risk%20of%20bleeding.%20Moreover%2C%20antithrombotics%20cannot%20completely%20prevent%20thrombotic%20events%2C%20implicating%20a%20therapeutic%20gap%20due%20to%20a%20third%2C%20not%20yet%20adequately%20addressed%20mechanism%2C%20namely%20inflammation.%20In%20this%20Review%2C%20we%20discuss%20how%20the%20synergy%20between%20inflammation%20and%20thrombosis%20drives%20thrombotic%20diseases.%20We%20focus%20on%20the%20huge%20potential%20of%20anti-inflammatory%20strategies%20to%20target%20cardiovascular%20pathologies.%20Findings%20in%20the%20past%20decade%20have%20uncovered%20a%20sophisticated%20connection%20between%20innate%20immunity%2C%20platelet%20activation%20and%20coagulation%2C%20termed%20immunothrombosis.%5Cu00a0Immunothrombosis%20is%20an%20important%20host%20defence%20mechanism%20to%20limit%20systemic%20spreading%20of%20pathogens%20through%20the%20bloodstream.%20However%2C%20the%20aberrant%20activation%20of%20immunothrombosis%20in%20cardiovascular%20diseases%20causes%20myocardial%20infarction%2C%20stroke%20and%20venous%20thromboembolism.%20The%20clinical%20relevance%20of%20aberrant%20immunothrombosis%2C%20referred%20to%20as%20thromboinflammation%2C%20is%20supported%20by%20the%20increased%20risk%20of%20cardiovascular%20events%20in%20patients%20with%20inflammatory%20diseases%20but%20also%20during%20infections%2C%20including%20in%20COVID-19.%20Clinical%20trials%20in%20the%20past%204%20years%20have%20confirmed%20the%20anti-ischaemic%20effects%20of%20anti-inflammatory%20strategies%2C%20backing%20the%20concept%20of%20a%20prothrombotic%20function%20of%20inflammation.%20Targeting%20inflammation%20to%20prevent%20thrombosis%20leaves%20haemostasis%20mainly%20unaffected%2C%20circumventing%20the%20risk%20of%20bleeding%20associated%20with%20current%20approaches.%20Considering%20the%20growing%20number%20of%20anti-inflammatory%20therapies%2C%20it%20is%20crucial%20to%20appreciate%20their%20potential%20in%20covering%20therapeutic%20gaps%20in%20cardiovascular%20diseases.%22%2C%22date%22%3A%222021-05-06%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41569-021-00552-1%22%2C%22ISSN%22%3A%221759-5010%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41569-021-00552-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-05-07T21%3A12%3A24Z%22%7D%7D%5D%7D
Stark, K., & Massberg, S. (2021). Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology, 1–17. https://doi.org/10.1038/s41569-021-00552-1 Cite